Literature DB >> 24927946

The impact of immigration and visible minority status on psychosis symptom profile.

Akiah Ottesen Berg1, Ole A Andreassen, Sofie Ragnhild Aminoff, Kristin Lie Romm, Edvard Hauff, Ingrid Melle.   

Abstract

PURPOSE: Immigrants have heightened risks of psychotic disorders, and it is proposed that migration influences symptom profiles. The purpose of this study was to investigate if either migration experience and/or visible minority status affected symptom profiles, using a cross-culturally validated five-factor model of the Positive and Negative Syndrome Scale (PANSS), in patients with broadly defined psychotic disorders.
METHODS: PANSS was assessed in a large catchment area based sample of patients with psychotic disorders verified with the Structured Clinical Interview for DSM-IV (n = 1,081). Symptom profiles based on Wallwork et al. five-factor model were compared for Norwegians (73 %), white immigrants (10.5 %), and visible minority groups (16.5 %).
RESULTS: Visible minorities were significantly younger, had less education, more often a schizophrenia diagnosis and higher PANSS positive, negative and disorganized/concrete factor scores than Norwegians and white immigrants. After controlling for confounders only the items "Delusions" and "Difficulty in abstract thinking" differed between groups. Multivariate analyses indicated that these items were not associated with immigration per se, but rather belonging to a visible minority.
CONCLUSION: We found mostly similarities in psychotic symptoms between immigrants and Norwegians when using a cross-culturally validated five-factor model of the PANSS. Immigration did not directly influence psychotic symptom profiles but visible minority groups had higher levels of "Delusions" and "Difficulty in abstract thinking", both symptoms that are partially context dependent.

Entities:  

Mesh:

Year:  2014        PMID: 24927946     DOI: 10.1007/s00127-014-0897-x

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  65 in total

1.  Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study.

Authors:  Ulrich Reininghaus; Thomas K J Craig; Helen L Fisher; Gerard Hutchinson; Paul Fearon; Kevin Morgan; Paola Dazzan; Gillian A Doody; Peter B Jones; Robin M Murray; Craig Morgan
Journal:  Schizophr Res       Date:  2010-09-19       Impact factor: 4.939

2.  Psychotic experiences: disadvantaged and different from the norm.

Authors:  Jim van Os
Journal:  Br J Psychiatry       Date:  2012-10       Impact factor: 9.319

3.  Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

Authors:  Deanna L Kelly; Lisa B Dixon; Julie A Kreyenbuhl; Deborah Medoff; Anthony F Lehman; Raymond C Love; Clayton H Brown; Robert R Conley
Journal:  J Clin Psychiatry       Date:  2006-09       Impact factor: 4.384

4.  Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence.

Authors:  J P Selten; J P Slaets; R S Kahn
Journal:  Psychol Med       Date:  1997-07       Impact factor: 7.723

Review 5.  Auditory hallucinations: a review of assessment tools.

Authors:  Kirk Ratcliff; John Farhall; Frances Shawyer
Journal:  Clin Psychol Psychother       Date:  2010-10-27

6.  Examination of treatment pattern differences by race.

Authors:  Tami L Mark; Liisa A Palmer; Patricia A Russo; Joseph Vasey
Journal:  Ment Health Serv Res       Date:  2003-12

Review 7.  Ethnic minority position and risk for psychotic disorders.

Authors:  Wim Veling
Journal:  Curr Opin Psychiatry       Date:  2013-03       Impact factor: 4.741

8.  Symptoms at first contact for psychotic disorder: comparison between native Dutch and ethnic minorities.

Authors:  Wim Veling; Jean-Paul Selten; Johan P Mackenbach; Hans W Hoek
Journal:  Schizophr Res       Date:  2007-07-31       Impact factor: 4.939

9.  Racial/Ethnic group differences in bipolar symptomatology in a community sample of persons with bipolar I disorder.

Authors:  Brian E Perron; Lauren E Fries; Amy M Kilbourne; Michael G Vaughn; Mark S Bauer
Journal:  J Nerv Ment Dis       Date:  2010-01       Impact factor: 2.254

10.  Migrant background and ethnic minority status as predictors for duration of untreated psychosis.

Authors:  Mari Nerhus; Akiah Ottesen Berg; Marit Haram; Levi Røstad Kvitland; Ole Andreas Andreassen; Ingrid Melle
Journal:  Early Interv Psychiatry       Date:  2013-11-14       Impact factor: 2.732

View more
  5 in total

1.  Is the Definition of Roma an Important Matter? The Parallel Application of Self and External Classification of Ethnicity in a Population-Based Health Interview Survey.

Authors:  Eszter Anna Janka; Ferenc Vincze; Róza Ádány; János Sándor
Journal:  Int J Environ Res Public Health       Date:  2018-02-16       Impact factor: 3.390

2.  Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestry.

Authors:  Nuwan C Hettige; Ali Bani-Fatemi; James L Kennedy; Vincenzo De Luca
Journal:  BMC Psychiatry       Date:  2017-02-09       Impact factor: 3.630

3.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for gXe research.

Authors:  James B Kirkbride
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-09-06       Impact factor: 4.328

4.  Depression, anxiety and suicidal ideation among 1(st) and 2(nd) generation migrants - results from the Gutenberg health study.

Authors:  Manfred E Beutel; Claus Jünger; Eva M Klein; Philipp Wild; Karl J Lackner; Maria Blettner; Mita Banerjee; Matthias Michal; Jörg Wiltink; Elmar Brähler
Journal:  BMC Psychiatry       Date:  2016-08-12       Impact factor: 3.630

5.  INTREPID II: protocol for a multistudy programme of research on untreated psychosis in India, Nigeria and Trinidad.

Authors:  Tessa Roberts; Oye Gureje; Rangaswamy Thara; Gerard Hutchinson; Alex Cohen; Helen Anne Weiss; Sujit John; Joni Lee Pow; Casswina Donald; Bola Olley; Georgina Miguel Esponda; Robin M Murray; Craig Morgan
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.